{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:24:41Z","timestamp":1759047881740},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s12022-013-9259-6","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T03:21:10Z","timestamp":1377055270000},"page":"169-176","source":"Crossref","is-referenced-by-count":5,"title":["Different CXCR4 Expression According to Various Histologic Subtype of Papillary Thyroid Carcinoma"],"prefix":"10.1007","volume":"24","author":[{"given":"Dong Yeob","family":"Shin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Il","family":"Jee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woong Youn","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Jig","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,22]]},"reference":[{"key":"9259_CR1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","volume":"361","author":"SI Sherman","year":"2003","unstructured":"Sherman SI. Thyroid carcinoma. Lancet 361:501\u201311, 2003.","journal-title":"Lancet"},{"key":"9259_CR2","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1210\/jc.82.5.1638","volume":"82","author":"F Arturi","year":"1997","unstructured":"Arturi F, Russo D, Giuffrida D, et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82:1638\u201341, 1997.","journal-title":"J Clin Endocrinol Metab"},{"key":"9259_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cncr.11442","volume":"98","author":"SM Chow","year":"2003","unstructured":"Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid\u2014prognostic significance of lymph node metastasis and multifocality. Cancer 98:31\u201340, 2003.","journal-title":"Cancer"},{"key":"9259_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/msy.2002.120657","volume":"131","author":"SW Qubain","year":"2002","unstructured":"Qubain SW, Nakano S, Baba M, Takao S, Aikou T. Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery 131:249\u201356, 2002.","journal-title":"Surgery"},{"key":"9259_CR5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1470-2045(07)70034-7","volume":"8","author":"E Baudin","year":"2007","unstructured":"Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol 8:148\u201356, 2007.","journal-title":"Lancet Oncol"},{"key":"9259_CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.18.1.217","volume":"18","author":"D Rossi","year":"2000","unstructured":"Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18:217\u201342, 2000.","journal-title":"Annu Rev Immunol"},{"key":"9259_CR7","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/ijc.22024","volume":"119","author":"A Zlotnik","year":"2006","unstructured":"Zlotnik A. Chemokines and cancer. Int J Cancer 119:2026\u20139, 2006.","journal-title":"Int J Cancer"},{"key":"9259_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jlb.66.3.455","volume":"66","author":"CH Kim","year":"1999","unstructured":"Kim CH, Broxmeyer HE. SLC\/exodus2\/6Ckine\/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation. J Leukoc Biol 66:455\u201361, 1999.","journal-title":"J Leukoc Biol"},{"key":"9259_CR9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2003.10.003","volume":"14","author":"F Balkwill","year":"2004","unstructured":"Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14:171\u20139, 2004.","journal-title":"Semin Cancer Biol"},{"key":"9259_CR10","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1210\/jc.86.7.3368","volume":"86","author":"G Aust","year":"2001","unstructured":"Aust G, Steinert M, Kiessling S, Kamprad M, Simchen C. Reduced expression of stromal-derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells. J Clin Endocrinol Metab 86:3368\u201376, 2001.","journal-title":"J Clin Endocrinol Metab"},{"key":"9259_CR11","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1038\/sj.onc.1207790","volume":"23","author":"MD Castellone","year":"2004","unstructured":"Castellone MD, Guarino V, De Falco V, et al. Functional expression of the CXCR4 chemokine receptor is induced by RET\/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Oncogene 23:5958\u201367, 2004.","journal-title":"Oncogene"},{"key":"9259_CR12","doi-asserted-by":"crossref","first-page":"11821","DOI":"10.1158\/0008-5472.CAN-07-0899","volume":"67","author":"V Falco De","year":"2007","unstructured":"De Falco V, Guarino V, Avilla E, et al. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer Res 67:11821\u20139, 2007.","journal-title":"Cancer Res"},{"key":"9259_CR13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1210\/jc.2002-021381","volume":"88","author":"JH Hwang","year":"2003","unstructured":"Hwang JH, Hwang JH, Chung HK, et al. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. J Clin Endocrinol Metab 88:408\u201316, 2003.","journal-title":"J Clin Endocrinol Metab"},{"key":"9259_CR14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/thy.2008.0432","volume":"19","author":"HE Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez HE, Leiva A, Tobar H, et al. Altered chemokine receptor expression in papillary thyroid cancer. Thyroid 19:957\u201365, 2009.","journal-title":"Thyroid"},{"key":"9259_CR15","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1245\/s10434-008-0064-2","volume":"15","author":"PL Wagner","year":"2008","unstructured":"Wagner PL, Moo T-A, Arora N, et al. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Ann Surg Oncol 15:2833\u201341, 2008.","journal-title":"Ann Surg Oncol"},{"key":"9259_CR16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50\u20136, 2001.","journal-title":"Nature"},{"key":"9259_CR17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121:335\u201348, 2005.","journal-title":"Cell"},{"key":"9259_CR18","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0503039102","volume":"102","author":"MG Borrello","year":"2005","unstructured":"Borrello MG, Alberti L, Fischer A, et al. Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene. Proc Natl Acad Sci USA 102:14825\u201330, 2005.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9259_CR19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1471-2407-8-274","volume":"8","author":"H Yasuoka","year":"2008","unstructured":"Yasuoka H, Kodama R, Hirokawa M, et al. CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis. BMC Cancer 8:274, 2008.","journal-title":"BMC Cancer"},{"key":"9259_CR20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.otohns.2005.02.002","volume":"132","author":"AR Burningham","year":"2005","unstructured":"Burningham AR, Krishnan J, Davidson BJ, Ringel MD, Burman KD. Papillary and follicular variant of papillary carcinoma of the thyroid: initial presentation and response to therapy. Otolaryngol Head Neck Surg 132:840\u20134, 2005.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"9259_CR21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/archsurg.138.12.1362","volume":"138","author":"C Passler","year":"2003","unstructured":"Passler C, Prager G, Scheuba C, et al. Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 138:1362\u20136, 2003.","journal-title":"Arch Surg"},{"key":"9259_CR22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/cncr.11175","volume":"97","author":"J Zidan","year":"2003","unstructured":"Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 97:1181\u20135, 2003.","journal-title":"Cancer"},{"key":"9259_CR23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0748-7983(03)00005-2","volume":"29","author":"SM Chow","year":"2003","unstructured":"Chow SM, Chan JK, Law SC, et al. Diffuse sclerosing variant of papillary thyroid carcinoma\u2014clinical features and outcome. Eur J Surg Oncol 29:446\u20139, 2003.","journal-title":"Eur J Surg Oncol"},{"key":"9259_CR24","first-page":"90","volume":"2","author":"AL Vickery Jr","year":"1985","unstructured":"Vickery AL, Jr., Carcangiu ML, Johannessen JV, Sobrinho-Simoes M. Papillary carcinoma. Semin Diagn Pathol 2:90\u2013100, 1985.","journal-title":"Semin Diagn Pathol"},{"key":"9259_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/thy.1998.8.385","volume":"8","author":"M Albareda","year":"1998","unstructured":"Albareda M, Puig-Domingo M, Wengrowicz S, et al. Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid 8:385\u201391, 1998.","journal-title":"Thyroid"},{"key":"9259_CR26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00000478-198912000-00006","volume":"13","author":"ML Carcangiu","year":"1989","unstructured":"Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 13:1041\u20139, 1989.","journal-title":"Am J Surg Pathol"},{"key":"9259_CR27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/thy.2009.0073","volume":"19","author":"JS Koo","year":"2009","unstructured":"Koo JS, Hong S, Park CS. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young. Thyroid 19:1225\u201331, 2009.","journal-title":"Thyroid"},{"key":"9259_CR28","doi-asserted-by":"crossref","unstructured":"Ito Y, Hirokawa M, Fukushima M, et al. Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J Surg 32:1535\u201343; discussion 44\u20135, 2008.","DOI":"10.1007\/s00268-007-9406-7"},{"key":"9259_CR29","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","volume":"31","author":"M Volante","year":"2007","unstructured":"Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256\u201364, 2007.","journal-title":"Am J Surg Pathol"},{"key":"9259_CR30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.prp.2010.05.003","volume":"206","author":"X He","year":"2010","unstructured":"He X, Wei Q, Zhang X, et al. Immunohistochemical expression of CXCR4 in thyroid carcinomas and thyroid benign lesions. Pathol Res Pract 206:712\u20135, 2010.","journal-title":"Pathol Res Pract"},{"key":"9259_CR31","doi-asserted-by":"crossref","unstructured":"Nikiforova MN, Kimura et, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399\u2013404, 2003.","DOI":"10.1210\/jc.2003-030838"},{"key":"9259_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1309\/ND8D9LAJTRCTG6QD","volume":"120","author":"Z Zhu","year":"2003","unstructured":"Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol 120:71\u20137, 2003.","journal-title":"Am J Clin Pathol"},{"key":"9259_CR33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1245\/ASO.2006.03.062","volume":"13","author":"AK Lam","year":"2006","unstructured":"Lam AK, Lo CY. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution. Ann Surg Oncol 13:176\u201381, 2006.","journal-title":"Ann Surg Oncol"},{"key":"9259_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1385\/EP:16:4:331","volume":"16","author":"LD Thompson","year":"2005","unstructured":"Thompson LD, Wieneke JA, Heffess CS. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases. Endocr Pathol 16:331\u201348, 2005.","journal-title":"Endocr Pathol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-013-9259-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-013-9259-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-013-9259-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T14:39:51Z","timestamp":1563719991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-013-9259-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,22]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["9259"],"URL":"https:\/\/doi.org\/10.1007\/s12022-013-9259-6","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,22]]}}}